Russian Conglomerate Eyes Investment in Indonesia's Pharmaceutical Sector

Potential Collaboration with State-Owned Enterprises

Sistema Group, a major Russian conglomerate, has expressed interest in investing in Indonesia's pharmaceutical industry. The company is considering collaboration with state-owned enterprises Biofarma and Kimia Farma to potentially manufacture pharmaceutical products in Indonesia ¹

Meeting with President Prabowo Subianto

The investment plans were discussed during a meeting between Sistema Group and President Prabowo Subianto at the Presidential Palace in Jakarta. Minister of Investment and Downstreaming/Chairman of BKPM, Rosan Roeslani, accompanied the President during the meeting ¹

Reducing Drug Prices

The Indonesian government hopes that this investment will help reduce drug prices in the country, which are currently relatively high compared to other nations. Rosan Roeslani stated that the government conveyed its hopes that the collaboration with Sistema Group could help lower drug prices in Indonesia ¹

Sistema Group's Healthcare Portfolio

Sistema Group is known for its extensive healthcare portfolio in Russia, including over 160 hospitals and a significant number of patented medicines. The conglomerate's interest in Indonesia's pharmaceutical sector is seen as a positive development for the country's healthcare industry ²

Next Steps

Initial discussions between Sistema Group and the Indonesian state-owned pharmaceutical companies took place in Bandung. Further follow-up actions are expected to materialize from these initial talks ³